DIMENSIONAL FUND ADVISORS LP - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$16,453,519
-18.6%
1,804,224
-5.6%
0.01%
-16.7%
Q2 2023$20,224,480
-9.9%
1,911,656
+4.2%
0.01%
-25.0%
Q1 2023$22,441,974
+106209.7%
1,835,084
+7.9%
0.01%
+33.3%
Q4 2022$21,110
-99.9%
1,701,172
+8.2%
0.01%
-25.0%
Q3 2022$21,482,000
-15.0%
1,572,657
+14.0%
0.01%
-11.1%
Q2 2022$25,287,000
+46.9%
1,379,615
+28.9%
0.01%
+80.0%
Q1 2022$17,217,000
+58.8%
1,070,685
+38.2%
0.01%
+66.7%
Q4 2021$10,844,000
-11.0%
774,510
+19.1%
0.00%
-25.0%
Q3 2021$12,179,000
-23.2%
650,241
-14.5%
0.00%
-20.0%
Q2 2021$15,854,000
-31.4%
760,307
-7.2%
0.01%
-37.5%
Q1 2021$23,104,000
+9.1%
819,092
+26.3%
0.01%0.0%
Q4 2020$21,183,000
+11.1%
648,510
+4.2%
0.01%0.0%
Q3 2020$19,072,000
+97.6%
622,464
+5.1%
0.01%
+100.0%
Q2 2020$9,652,000
+75.5%
592,095
+7.1%
0.00%
+33.3%
Q1 2020$5,500,000
-26.6%
552,909
+1.4%
0.00%0.0%
Q4 2019$7,495,000
-8.1%
545,037
+1.3%
0.00%0.0%
Q3 2019$8,158,000
-22.3%
537,857
+0.8%
0.00%
-25.0%
Q2 2019$10,503,000
+61.9%
533,407
+36.4%
0.00%
+33.3%
Q1 2019$6,486,000
+191.9%
390,993
+147.1%
0.00%
+200.0%
Q4 2018$2,222,000158,2600.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders